The Four Devices We Do Not Compete With and Why

Medically reviewed by

4 independent reviewers

Andrew Conrad Barile, PT, DPT

Andrew Conrad Barile, PT, DPT

Doctor of Physical Therapy (DPT) | Licensed Physical Therapist (PT) | CEO and Founder, Xtreem Pulse LLC

Read bio

Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC, the engineering company behind PureLift. He earned his Doctorate in Physical Therapy from Daemen College and is a licensed physical therapist.

He brings over two decades of clinical and entrepreneurial experience across physical therapy, craniosacral therapy and medical device innovation, built on a working knowledge of human anatomy and muscle physiology.

For PureLift LAB he reviews how current is delivered across all ten levels, from sub-sensory nanocurrent and skin-level microcurrent to motor-level EMS, and how the Infuse pass fits into the same ten-minute routine.

Bertica M. Rubio, M.D.

Bertica M. Rubio, M.D.

Board-Certified Physician, Dartmouth Medical School | Medical Director, Antiaging Regenerative Medicine Clinic

Read bio

Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Doctor of Medicine from Dartmouth Medical School and completed her pediatrics residency at UC Irvine Medical Center.

With decades of clinical experience, she specialises in age management medicine, regenerative medicine, wound healing and growth factor therapies, and her practice integrates evidence-based medical science with advanced aesthetic treatment.

For PureLift LAB she reviews articles for medical accuracy across the whole dial, from the gentle nanocurrent and microcurrent settings through to muscle-level EMS and the Infuse pass.

Daniel Grinberg, MD, FACS

Daniel Grinberg, MD, FACS

Board-Certified Otolaryngologist | Head and Neck Surgeon | Fellow, American College of Surgeons | Mount Sinai

Read bio

Daniel Grinberg, MD, FACS is a board-certified otolaryngologist and head and neck surgeon at ENT and Allergy Associates in West Nyack, New York. He earned his medical degree from Columbia University College of Physicians and Surgeons.

He completed his otolaryngology residency at New York University Medical Center, serves as Assistant Clinical Professor at Mount Sinai School of Medicine, and is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.

For PureLift LAB he brings a wider clinical lens, connecting at-home facial stimulation from microcurrent to EMS to the anatomy underneath, with the same rigour we apply to every device specification.

Prof. Dr. med. Ivo Buschmann

Prof. Dr. med. Ivo Buschmann

Chair of Angiology, Medizinische Hochschule Brandenburg | Clinic Director, University Clinic for Angiology

Read bio

Prof. Dr. med. Ivo Buschmann is Chair of Angiology at the Medizinische Hochschule Brandenburg Theodor Fontane and Clinic Director of the University Clinic for Angiology at the Brandenburg University Hospital.

He trained at the University of Hamburg, was a Max Planck Society Fellow at the Max Planck Institute for Heart and Lung Research, and held senior consultant posts at the Charite Universitatsmedizin Berlin before his appointment as Chair in 2016.

One of Europe's leading authorities on arteriogenesis, with over 150 peer-reviewed publications and US and EU patents, he reviews for PureLift LAB how the evidence on electrical stimulation is read and where its limits lie.

What's This About:

Four at-home devices in this market do something PureLift does not do at all, and for some buyers one of them is the right purchase instead of ours.

This article covers what actually decides the answer, such as:

- what a laser does to skin that a current cannot

- what radiofrequency heating is actually for

- which competitor genuinely contracts a facial muscle

- what each one costs to run, including the gels

- how to tell which problem you actually have

and many more!

We publish this because a comparison where we win every category would not be worth reading.

Key Points:

Lasers and radiofrequency work on the dermis, the collagen scaffold of the skin; EMS works on the muscle underneath it.

LYMA is a 808 nm low-level laser at about 62.5 mW/cm2 over 8 square centimetres, cleared under K210823, at GBP 1,999.

NIRA uses a 1450 nm laser at a water absorption peak, cleared under K163137 for periorbital wrinkles only, at $449 and with no consumables.

TriPollar's STOP Vx includes DMA, which Pollogen describes as activating the motor endplate, so it is the one competitor here that does stimulate muscle.

NEWA holds a De Novo, DEN150005, and publishes 1 MHz, 10 W and a 42 degree cutoff, which is the most complete disclosure of the four.

Three technologies, three targets

A low-level laser such as LYMA's delivers light at a power density too low to heat tissue meaningfully, aiming instead at cellular photobiomodulation.

A 1450 nm laser such as NIRA's is absorbed by water, so the energy deposits as heat in the dermis and creates a controlled sub-injury that triggers a repair response.

Radiofrequency such as TriPollar's, NEWA's and Silk'n's passes current through tissue, meets resistance, and produces heat that stops short of the temperature at which collagen contracts, prompting fibroblasts to build new collagen over weeks.

All three change the quality and thickness of the skin envelope. EMS changes the tone of the muscle the skin is draped over. Neither substitutes for the other.

LYMA, the expensive one with a real reason to exist

GBP 1,999 for the starter kit, with an 808 nm near infrared beam and 620 nm red, 500 mW across an 8 square centimetre lens, which works out at about 62.5 mW/cm2.

Three minutes per area daily for the first twelve weeks, then three times a week, with an oxygen mist and glide supplied as a thirty-day supply.

It is the only device in this group that does not work by heating tissue, which makes it the sensible choice for someone with reactive or flushing-prone skin who does not tolerate heat-based treatment.

LYMA does not publish a refill price on its own site and does not state a country of manufacture, which at that price is a gap worth noting.

Its elasticity and pigmentation figures are relative changes on specific measures rather than anything a mirror will show as a doubling.

NIRA, the narrowest and cleanest

$449 for the Precision, two minutes a day, no gel, no serum, no consumables at all, and made in the USA per the brand.

Its clearance, K163137, covers periorbital wrinkles, which is exactly what the device is for.

For etched fine lines around the eyes, where there is very little muscle bulk to work with and the problem is genuinely dermal, this is a better tool than any muscle-stimulation device including ours.

One caution: the larger Pro model is marketed for neck, chest and hands while the clearance on file covers the eye area, and the company acknowledges it plans to seek further clearance.

Neither page publishes laser class or output power in milliwatts, and the contraindication information is thin.

TriPollar, the one that does stimulate muscle

The STOP Vx line at around $699 combines multipolar radiofrequency with DMA, which Pollogen describes in its own words as delivering electrical current that activates the motor endplate of the muscle.

That is muscle stimulation by any reasonable definition, and it makes TriPollar the only device in this group doing anything comparable to what we do.

Pollogen does not publish the DMA current parameters for the home device, nor the RF frequency, wattage or temperature cap, so there is no figure to compare against our 9 mA at 500 ohms.

The activator gel is required at roughly $53 a bottle per six to eight week cycle, which is the highest running cost in this group.

It also carries by far the longest contraindication list, including pacemakers, metal implants, permanent fillers, diabetes and cancer history.

NEWA, the best documented device in this article

From $339, and it holds a De Novo rather than a 510(k), meaning the FDA reviewed it as a new device type rather than against a predicate.

That grant publishes what the brand does not have to: 1 MHz, 10 W, and a thermal sensor that stops delivery at 42 degrees Celsius.

The protocol is demanding, four minutes across six facial areas five times a week for four weeks, which is roughly two hours a week at the start, and adherence is where these devices usually fail.

It is indicated for Fitzpatrick skin types one to four, so if your skin is deeper than that, it is not cleared for you.

Gel runs $29 a bottle.

How to tell which problem you have

Pinch the skin on your cheek gently. If it feels thin, crepey and slow to settle, the complaint is dermal, and RF or a laser addresses it more directly than we do.

Look at your jawline and the line from cheekbone to chin. If the shape has changed rather than the surface, that is contour, and contour sits on muscle.

Most people over forty have some of both, which is why these devices stack rather than compete, and why we have no interest in telling you RF does not work.

What we will not agree with is a device claiming to do both jobs without publishing what it delivers for either.

Where we do compete

PureLift runs from Face at $499 to GLOW at $999, all publishing output at a stated load, all cleared, all made in Japan in an ISO 13485 facility since 1987.

Kavanagh and colleagues measured an 18.6 percent increase in cheek muscle thickness over twelve weeks of motor-level stimulation (10.1111/jocd.12007), which is the mechanism we are built around.

If the muscle layer is your problem, that is our argument, and it is the only argument we are making.

This comparison sits inside our full map of the category, where we set out all 33 devices we track, what each one carries and what each brand publishes: Nine Technologies on One Dial, What the Rest of the Market Actually Carries.

Prices, specifications and clearance records verified on 21 September 2026 against each brand's own published material and the FDA 510(k) and De Novo databases.

Back to blog